The National Medical Products Administration (NMPA) of China and the Ministry of Food and Drug Safety (MFDS) of South Korea have renewed their Memorandum of Understanding (MOU) to enhance regulatory cooperation in the sectors of drugs, medical devices, and cosmetics. Originally established in 2019, the MOU aims to intensify exchange and collaboration between the two countries, ensuring robust regulatory frameworks and fostering innovation in healthcare and beauty industries.
This renewal signifies a continued commitment by both parties to work closely on regulatory harmonization, information sharing, and joint initiatives to address common challenges and promote industry growth.- Flcube.com
